While tumor-infiltrating myeloid cells from control mice did not affect neoplastic cell number, CD11b+ cells from CCR1 and CCR5 shRNA treated mice drastically reduced the number of 4T1 cells in culture indicating a tumoricidal action. The gene discussed is CCR1; the disease is neoplasm.